CHORDOMA

Clinical trials for CHORDOMA explained in plain language.

Never miss a new study

Get alerted when new CHORDOMA trials appear

Sign up with your email to follow new studies for CHORDOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 7 Completed 1

New combo therapy for rare spine tumor shows promise in early trial

Disease control Completed

This early-phase study tested the safety of adding nilotinib, a drug that targets a specific growth signal in chordoma cells, to standard radiation therapy for people with high-risk chordoma. The goal was to find the highest safe dose of nilotinib when combined with radiation. Tw…

Matched conditions: CHORDOMA

Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control

Last updated May 14, 2026 12:06 UTC

CHORDOMA

Get alerted when new CHORDOMA trials appear

New combo therapy for rare spine tumor shows promise in early trial